Lisa Gill
Stock Analyst at JP Morgan
(3.37)
# 1,008
Out of 4,981 analysts
126
Total ratings
49.41%
Success rate
3.94%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMI Owens & Minor | Maintains: Underweight | $7 → $6 | $5.34 | +12.36% | 5 | Aug 27, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $418 → $310 | $352.51 | -12.06% | 9 | Aug 6, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $472 → $384 | $311.76 | +23.17% | 5 | Jul 22, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $29 → $32 | $22.79 | +40.41% | 5 | May 28, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $180 → $190 | $182.91 | +3.88% | 3 | May 6, 2025 | |
| CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $22.15 | +35.44% | 2 | Mar 19, 2025 | |
| OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $28.48 | +43.99% | 4 | Mar 6, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $16.04 | +5.99% | 4 | Mar 6, 2025 | |
| HUM Humana | Maintains: Neutral | $257 → $256 | $276.44 | -7.39% | 6 | Feb 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $81 | $74.98 | +8.03% | 5 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $142 → $145 | $152.24 | -4.76% | 6 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $289 → $301 | $302.52 | -0.50% | 2 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $9.75 | +84.62% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $4.52 | +10.74% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $21.87 | +28.03% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $7.68 | +17.19% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $656 → $661 | $711.42 | -7.09% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $302.76 | +44.67% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $13.08 | +37.61% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $180.88 | +118.38% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $277.95 | -12.57% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $191.72 | -2.98% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $192.82 | -27.39% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $405.13 | -18.05% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.19 | +138.66% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $1.07 | +741.12% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $8.44 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $5.23 | +52.96% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $69.01 | +20.27% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $33.26 | +194.65% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $26.60 | - | 4 | Dec 19, 2017 |
Owens & Minor
Aug 27, 2025
Maintains: Underweight
Price Target: $7 → $6
Current: $5.34
Upside: +12.36%
UnitedHealth Group
Aug 6, 2025
Maintains: Overweight
Price Target: $418 → $310
Current: $352.51
Upside: -12.06%
Elevance Health
Jul 22, 2025
Maintains: Overweight
Price Target: $472 → $384
Current: $311.76
Upside: +23.17%
Privia Health Group
May 28, 2025
Maintains: Overweight
Price Target: $29 → $32
Current: $22.79
Upside: +40.41%
Quest Diagnostics
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $182.91
Upside: +3.88%
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $22.15
Upside: +35.44%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $28.48
Upside: +43.99%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $16.04
Upside: +5.99%
Humana
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $276.44
Upside: -7.39%
CVS Health
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $74.98
Upside: +8.03%
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $152.24
Upside: -4.76%
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $302.52
Upside: -0.50%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $9.75
Upside: +84.62%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $4.52
Upside: +10.74%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $21.87
Upside: +28.03%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $7.68
Upside: +17.19%
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $711.42
Upside: -7.09%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $302.76
Upside: +44.67%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $13.08
Upside: +37.61%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $180.88
Upside: +118.38%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $277.95
Upside: -12.57%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $191.72
Upside: -2.98%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $192.82
Upside: -27.39%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $405.13
Upside: -18.05%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.19
Upside: +138.66%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $1.07
Upside: +741.12%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $8.44
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $5.23
Upside: +52.96%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $69.01
Upside: +20.27%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $33.26
Upside: +194.65%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $26.60
Upside: -